CataRhex 3® - Strong, Beautiful, Unique – For You

Article

CataRhex 3 ? Phaco without Limits Never before has cutting-edge technology for anterior segment surgery been as easily and reliably available, and never before has its packaging been more compact and tempting.

CataRhex 3® - Strong, Beautiful, Unique – For You

Weighing as little as 5 kg and fitting in any pilot case, CataRhex 3® can be mounted on any IV pole with a click – it is thus the epitome of portable equipment. A device that takes up so little space and is so easy to handle is becoming increasingly attractive in both outpatient and high-volume clinics. After all, CataRhex3® offers the latest phaco technology, from clear lens exchange to the hardest lenses. CataRhex 3 easyPhaco® Technology is available for 1.6, 2.2 and 2.8mm incisions with unparalleled efficiency and chamber stability. The newly developed CortexModeTM makes I/A with capsule cleaning noticeably safer and faster. Anterior vitrectomies can be precisely controlled with the high-precision flow control and the pneumatic Twinac cutting instrument and thanks to the integrated air pressure compressor they are available at all times.

CataRhex 3® is a trend-setter: the HFDS® ab interno function provides MIGS technology which elegantly enables combined glaucoma/phaco surgery. In terms of femto LRCS, too, CataRhex 3® excels with perfect fragment aspiration.

Contact details:
Fabienne Kast, Product Manager Anterior
fabienne.kast@oertli-instruments.comwww.oertli-catarhex3.com

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.